Synthetic Lethality — A New Direction in Cancer-Drug Development
J. D. Iglehart
and
D. P. Silver
- 9 Jul, 2009
This article requires a subscription.
Login via Athens or your institution
Already a print subscriber? Activate your online access
Not a Subscriber?
